The Sleep Apnea–Specific Pulse-Rate Response Predicts Cardiovascular Morbidity and Mortality
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Abstract Rationale Randomized controlled trials have been unable to detect a cardiovascular benefit of continuous positive airway pressure in unselected patients with obstructive sleep apnea (OSA). We hypothesize that deleterious cardiovascular outcomes are concentrated in a subgroup of patients with a heightened pulse-rate response to apneas and hypopneas (ΔHR). Methods We measured the ΔHR in the MESA (Multi-Ethnic Study of Atherosclerosis) (N = 1,395) and the SHHS (Sleep Heart Health Study) (N = 4,575). MESA data were used to determine the functional form of the association between the ΔHR and subclinical cardiovascular biomarkers, whereas primary analyses tested the association of the ΔHR with nonfatal or fatal cardiovascular disease (CVD) and all-cause mortality in longitudinal data from the SHHS. Measurements and Main Results In the MESA, U-shaped relationships were observed between subclinical CVD biomarkers (coronary artery calcium, NT-proBNP [N-terminal prohormone BNP], and Framingham risk score) and the ΔHR; notably, a high ΔHR (upper quartile) was associated with elevated biomarker scores compared with a midrange ΔHR (25th–75th centiles). In the SHHS, individuals with a high ΔHR compared with a midrange ΔHR were at increased risk of nonfatal or fatal CVD and all-cause mortality (nonfatal adjusted hazard ratio [95% confidence interval (CI)], 1.60 [1.28–2.00]; fatal adjusted hazard ratio [95% CI], 1.68 [1.22–2.30]; all-cause adjusted hazard ratio [95% CI], 1.29 [1.07–1.55]). The risk associated with a high ΔHR was particularly high in those with a substantial hypoxic burden (nonfatal, 1.93 [1.36–2.73]; fatal, 3.50 [2.15–5.71]; all-cause, 1.84 [1.40–2.40]) and was exclusively observed in nonsleepy individuals. Conclusions Individuals with OSA who demonstrate an elevated ΔHR are at increased risk of cardiovascular morbidity and mortality. This study identifies a prognostic biomarker for OSA that appears useful for risk stratification and patient selection for future clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491 · cited 1×
“Outcomes for these analyses were continuously measured indices of subclinical CVD, chosen on the basis of their strong ability to predict long-term cardiovascular endpoints (such as coronary heart disease, arterial hypertension, and heart failure) (20, 21): 1) the coronary arterial calcium (CAC) score, measured with e…”
MethodEpidemiology of Obstructive Sleep Apnea: A Population Health Perspective
Young, T., Peppard, P. E., & Gottlieb, D. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2109080 · Cited by 4,244 · cited 1×
“This heterogeneity may be partly related to differences in the acute physiological consequences of the upper-airway obstructions during sleep (11), including intermittent hypoxia/hypercapnia, arousals, and intrathoracic pressure swings, all of which can activate the autonomic nervous system (12, 13).”
BackgroundSelf-citationSympathetic neural mechanisms in obstructive sleep apnea.
Somers, V. K., Dyken, M. E., Clary, M. P., & Abboud, F. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118235 · Cited by 2,527
Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study
Heinzer, R., Vat, S., Marques-Vidal, P., Marti-Soler, H., Andries, D., Tobback, N., Mooser, V, Preisig, M., Malhotra, A., Waeber, G., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00043-0 · Cited by 2,481 · cited 1×
“Obstructive sleep apnea (OSA) is a common chronic disorder (1) associated with hypertension, cardiovascular disease (CVD), metabolic dysfunction (2), and increased mortality (3).”
BackgroundCPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea
McEvoy, R. D., Antic, N. A., Heeley, E., Luo, Y., Ou, Q., Zhang, X., Mediano, O., Chen, R., Drager, L. F., Liu, Z., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606599 · Cited by 2,101
Self-citationSleep-Disordered Breathing and Mortality: A Prospective Cohort Study
Punjabi, N. M., Caffo, B. S., Goodwin, J. L., Gottlieb, D. J., Newman, A. B., O'Connor, G. T., Rapoport, D. M., Redline, S., Resnick, H. E., Robbins, J. A., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000132 · Cited by 1,482 · cited 5×
“Obstructive sleep apnea (OSA) is a common chronic disorder (1) associated with hypertension, cardiovascular disease (CVD), metabolic dysfunction (2), and increased mortality (3).”
BackgroundMethodSelf-citationDiagnosis and Management of Obstructive Sleep Apnea: A Review
Gottlieb, D. J., & Punjabi, N. M. (2020) · JAMA · doi:10.1001/jama.2020.3514 · Cited by 1,482 · cited 1×
“demonstrate a reduction in CVD events or mortality (4, 6, 7), posing a significant challenge to therapeutic decision-making in individuals with OSA (8).”
BackgroundSelf-citationYaffe, K., Laffan, A. M., Harrison, S. L., Redline, S., Spira, A. P., Ensrud, K. E., Ancoli-Israel, S., & Stone, K. L. (2011) · JAMA · doi:10.1001/jama.2011.1115 · Cited by 1,137
Self-citationResting Heart Rate in Cardiovascular Disease
Fox, K., Borer, J. S., Camm, A. J., Danchin, N., Ferrari, R., Lopez Sendon, J. L., Steg, P. G., Tardif, J.-C., Tavazzi, L., & Tendera, M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.079 · Cited by 1,062
Azarbarzin, A., Sands, S. A., Stone, K. L., Taranto-Montemurro, L., Messineo, L., Terrill, P. I., Ancoli-Israel, S., Ensrud, K., Purcell, S., White, D. P., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy624 · Cited by 893 · cited 4×
“These metrics were shown to more consistently correlate with incident heart failure (30), cardiovascularly related deaths, and all-cause mortality (24, 34).”
BackgroundMethodSelf-citation
Cited by
Metrics of sleep apnea severity: beyond the apnea-hypopnea index
Malhotra, A., Ayappa, I., Ayas, N., Collop, N., Kirsch, D., Mcardle, N., Mehra, R., Pack, A. I., Punjabi, N., White, D. P., et al. (2021) · SLEEP · doi:10.1093/sleep/zsab030 · Cited by 489
Self-citationObstructive sleep apnoea heterogeneity and cardiovascular disease
Redline, S., Azarbarzin, A., & Peker, Y. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00846-6 · Cited by 325
Self-citationTrzepizur, W., Blanchard, M., Ganem, T., Balusson, F., Feuilloy, M., Girault, J.-M., Meslier, N., Oger, E., Paris, A., Pigeanne, T., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202105-1274oc · Cited by 301
Metadata
- Authors
- Azarbarzin, A., Sands, S. A., Younes, M., Taranto-Montemurro, L., Sofer, T., Vena, D., Alex, R. M., Kim, S.-W., Gottlieb, D. J., White, D. P., Redline, S., & Wellman, A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-06-15
- Volume
- 203
- Issue
- 12
- Pages
- 1546-1555
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W3120925701
- Cited by
- 205
- References
- 18
- FWCI
- 16.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Sleep Apnea–Specific Pulse-Rate Response Predicts Cardiovascular Morbidity and Mortality. https://app.cochat.ai/papers/10.1164/rccm.202010-3900oc
- The paper
- Azarbarzin, A., Sands, S. A., Younes, M., Taranto-Montemurro, L., Sofer, T., Vena, D., Alex, R. M., Kim, S.-W., Gottlieb, D. J., White, D. P., Redline, S., & Wellman, A. (2021). The Sleep Apnea–Specific Pulse-Rate Response Predicts Cardiovascular Morbidity and Mortality. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.202010-3900oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.